The main features of randomized clinical trials performed in the field of hypertension treatment are reviewed, based either on the evaluation of clinical events or on the assessment of surrogate outcome measures. The advantages, limitations, and clinical relevance of each approach are highlighted. Copyright © 2005 by Current Science Inc.
Grassi, G. (2005). Intermediate versus hard end points in clinical trials on hypertension. CURRENT HYPERTENSION REPORTS, 7(4), 294-297 [10.1007/s11906-005-0028-x].
Intermediate versus hard end points in clinical trials on hypertension
Grassi, Guido
2005
Abstract
The main features of randomized clinical trials performed in the field of hypertension treatment are reviewed, based either on the evaluation of clinical events or on the assessment of surrogate outcome measures. The advantages, limitations, and clinical relevance of each approach are highlighted. Copyright © 2005 by Current Science Inc.
File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
